Seller record · zypmed.com

ZYP Medical

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The peptide, NAD+ and pricing pages stop at a licensed 503A pharmacy or licensed compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

ZYP Medicalzypmed.com

6/8criteria passed
Price
Semaglutide $399 for a 10-week starter plan
Sells
compounded semaglutide, compounded tirzepatide injection and oral, and 8 more
FDA letters
None on file
Visit ZYP MedicalSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Nebraska nurse practitioner practice with a Gretna clinic and telehealth in seven states, selling compounded semaglutide and tirzepatide starter plans and a peptide program that includes BPC-157, TB-500, GHK-Cu, sermorelin and ipamorelin. It prints every plan price and names no filling pharmacy.

Operating entity ZYP Medical, LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSzypmed.com, zypmed.com/peptide-therapy
S2Prescription gatingPASSzypmed.com/glp1-weight-loss-pricing, zypmed.com/peptide-therapy
S3Pharmacy identificationFAILzypmed.com/peptide-therapy, zypmed.com/nad-plus-therapy
S4Compounding disclosurePASSzypmed.com, zypmed.com/glp1-education, zypmed.com/peptide-therapy
S5Analytical documentationFAILzypmed.com/peptide-therapy
S6Business addressPASSzypmed.com
S7Price disclosurePASSzypmed.com/glp1-weight-loss-pricing, zypmed.com, zypmed.com/peptide-therapy
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery treatment is prescribed by a licensed family nurse practitioner after a consultation, and the peptide page states the provider may decide peptide therapy is not appropriate.Source: zypmed.com, zypmed.com/peptide-therapy.
S2PASSEvery order button opens a consultation booking with the provider, and medication is prescribed only when clinically appropriate after that visit.Source: zypmed.com/glp1-weight-loss-pricing, zypmed.com/peptide-therapy.
S3FAILThe site names no filling pharmacy. The peptide, NAD+ and pricing pages stop at a licensed 503A pharmacy or licensed compounding pharmacies.Source: zypmed.com/peptide-therapy, zypmed.com/nad-plus-therapy.
S4PASSCompounded semaglutide and tirzepatide are not FDA-approved and are prescribed off-label, printed on the home page and the education page, and the peptide page carries a banner stating the peptides are not FDA approved.Source: zypmed.com, zypmed.com/glp1-education, zypmed.com/peptide-therapy.
S5FAILTested for potency and sterility is a claim with no document behind it. No certificate or lot report is published on the peptide page or anywhere else on the site.Source: zypmed.com/peptide-therapy.
S6PASSZYP Medical, LLC at 11922 Standing Stone Dr, Suite 200, Gretna, NE 68028, printed in the footer of every page and described as the clinic location.Source: zypmed.com.
S7PASSSemaglutide at $399 for a 10-week starter plan or $449 for 12 weeks, and tirzepatide at $450 for a 2-month starter or $649 for three months, a plan the page says dropped from $699.99. The home page still prints tirzepatide at $233 a month, a consult is billed separately at $50 or $29.99, and BPC-157 is $289 for a 30-day supply.Source: zypmed.com/glp1-weight-loss-pricing, zypmed.com, zypmed.com/peptide-therapy.
S8PASSNo FDA warning letter names ZYP Medical or the operating entity ZYP Medical, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide injection and oral, BPC-157, TB-500, GHK-Cu injection and cream, KPV, ipamorelin with CJC-1295, sermorelin, NAD+, testosterone.

Unpaid link. ZYP Medical does not pay the site, and nothing is earned when it is used. Funding.

Visit ZYP Medical

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.